{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and posted_year = 2011 sorted by posted_date descending", "rows": [["FDA-2008-D-0659-0034", "FDA", "FDA-2008-D-0659", "Guidance for Industry Current Good Tissue Practice and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products; Availability", "Notice", "Notice of Availability", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2024-11-11T21:35:46Z", "2011-33572", 1, 0, "0900006480f8b716"], ["FDA-2011-N-0002-0153", "FDA", "FDA-2011-N-0002", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:13:50Z", "2011-33552", 0, 0, "0900006480f8b71a"], ["FDA-2011-D-0028-0003", "FDA", "FDA-2011-D-0028", "Medical Devices: Ovarian Adnexal Mass Assessment Score Test System; Labeling; Black Box Restrictions", "Rule", "Final Rule", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:31:25Z", "2011-33588", 0, 0, "0900006480f8b788"], ["FDA-2011-N-0002-0155", "FDA", "FDA-2011-N-0002", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:38:03Z", "2011-33548", 0, 0, "0900006480f8b7c4"], ["FDA-2011-D-0868-0001", "FDA", "FDA-2011-D-0868", "Draft Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices; Availability", "Notice", "Notice of Availability", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-03-30T03:59:59Z", "2020-04-29T00:35:05Z", "2011-33550", 0, 0, "0900006480f8b728"], ["FDA-2011-D-0872-0002", "FDA", "FDA-2011-D-0872", "Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies", "Other", "Guidance", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2011-03-30T03:59:59Z", "2011-12-30T13:38:31Z", null, 0, 0, "0900006480f8b808"], ["FDA-2011-N-0827-0001", "FDA", "FDA-2011-N-0827", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Labeling Requirements for Blood and Blood Components, Including Source Plasma; Revisions", "Notice", "General Notice", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-02-29T04:59:59Z", "2011-12-30T14:28:59Z", "2011-33555", 0, 0, "0900006480f8b750"], ["FDA-2011-D-0868-0002", "FDA", "FDA-2011-D-0868", "Draft Guidance for Industry on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices", "Other", "Citizen Petition", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2024-11-07T23:55:25Z", null, 1, 0, "0900006480f8b82a"], ["FDA-2009-N-0247-0300", "FDA", "FDA-2009-N-0247", "Report on Good Guidance Practices Improving Efficiency and Transparency; Availability", "Notice", "Availability of Document", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-02-29T04:59:59Z", "2011-12-30T14:36:05Z", "2011-33573", 0, 0, "0900006480f8b7c2"], ["FDA-2011-N-0002-0154", "FDA", "FDA-2011-N-0002", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T14:26:10Z", "2011-33561", 0, 0, "0900006480f8b74c"], ["FDA-2008-P-0555-0004", "FDA", "FDA-2008-P-0555", "Determinations that Drugs Were Not Withdrawn from Sale for Reasons of Safety or Effectiveness: HYCODAN", "Notice", "General Notice", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", null, "2011-12-30T13:50:53Z", "2011-33549", 0, 0, "0900006480f8b709"], ["FDA-2011-D-0872-0001", "FDA", "FDA-2011-D-0872", "Draft Guidance for Industry on Use of Histology in Biomarker Qualification Studies; Availabilty", "Notice", "Notice of Availability", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-03-30T03:59:59Z", "2013-11-23T02:02:25Z", "2011-33553", 0, 0, "0900006480f8b6cb"], ["FDA-2011-N-0619-0002", "FDA", "FDA-2011-N-0619", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Medical Devices; Humanitarian Use Devices", "Notice", "General Notice", "2011-12-30T05:00:00Z", 2011, 12, "2011-12-30T05:00:00Z", "2012-01-31T04:59:59Z", "2011-12-30T13:41:14Z", "2011-33551", 0, 0, "0900006480f8b6e5"], ["FDA-1991-P-0165-0002", "FDA", "FDA-1991-P-0165", "FDA/CDRH Hydergine Memo, dated 12/28/2011 to Division of Dockets Management", "Other", "Memo", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", null, "2024-11-12T04:15:45Z", null, 1, 0, "0900006480f8ae25"], ["FDA-2011-N-0003-0057", "FDA", "FDA-2011-N-0003", "Freedom of Information Summary ANDA 200-318 Bimectin Pour-On (Ivermectin)", "Supporting & Related Material", "Reference (internal unless indicated)", "2011-12-29T05:00:00Z", 2011, 12, null, null, "2011-12-29T14:03:11Z", null, 0, 0, "0900006480f8ad17"], ["FDA-2011-N-0003-0056", "FDA", "FDA-2011-N-0003", "Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution", "Rule", "Final Rule", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", null, "2011-12-29T13:58:17Z", "2011-33382", 0, 0, "0900006480f8acdf"], ["FDA-2011-N-0345-0003", "FDA", "FDA-2011-N-0345", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Experimental Study on Consumer Responses to Nutrition Facts Labels, etc.", "Notice", "General Notice", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", "2012-01-31T04:59:59Z", "2014-06-14T01:03:15Z", "2011-33303", 0, 0, "0900006480f8abb7"], ["FDA-1995-P-0246-0002", "FDA", "FDA-1995-P-0246", "Memorandum from FDA CDER to FDA DDM", "Other", "Memorandum", "2011-12-29T05:00:00Z", 2011, 12, "2011-12-29T05:00:00Z", null, "2025-09-15T23:09:53Z", null, 1, 0, "0900006480f8ae55"], ["FDA-1997-S-0006-1140", "FDA", "FDA-1997-S-0006", "Indiana Botanic Gardens, Inc., LET1140 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T19:17:21Z", null, 0, 0, "0900006480f85d4d"], ["FDA-1997-S-0006-1137", "FDA", "FDA-1997-S-0006", "New Century Company LET1137 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T18:47:38Z", null, 0, 0, "0900006480f85d47"], ["FDA-2011-P-0913-0002", "FDA", "FDA-2011-P-0913", "Acknowledgement Letter to KVK-Tech, Inc.", "Other", "Acknowledgement Letter/Receipt", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T23:00:45Z", null, 0, 0, "0900006480f847f9"], ["FDA-2011-P-0923-0001", "FDA", "FDA-2011-P-0923", "Public Citizen Health Research Group - Citizen Petition", "Other", "Citizen Petition", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2012-08-08T18:44:33Z", null, 0, 0, "0900006480f88963"], ["FDA-2011-D-0652-0001", "FDA", "FDA-2011-D-0652", "Draft Guidances for Industry and Staff; Availability: 510(k) Program, Evaluating Substantial Equivalence in Premarket Notifications; Availability", "Notice", "Notice of Availability", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-04-27T03:59:59Z", "2012-05-25T02:00:27Z", "2011-33232", 0, 0, "0900006480f8a26b"], ["FDA-1997-S-0006-1141", "FDA", "FDA-1997-S-0006", "Cobalis Corporation LET1141 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T19:23:16Z", null, 0, 0, "0900006480f85d4f"], ["FDA-1997-S-0006-1136", "FDA", "FDA-1997-S-0006", "Country Life LET1136 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T17:27:48Z", null, 0, 0, "0900006480f85d45"], ["FDA-1997-S-0006-1143", "FDA", "FDA-1997-S-0006", "New Chapter, Inc., LET1143 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T19:50:27Z", null, 0, 0, "0900006480f85d53"], ["FDA-2011-N-0912-0001", "FDA", "FDA-2011-N-0912", "Communications and Activities: Off-Label Uses of Marketed Products and Use of Products Not Yet Legally Marketed", "Notice", "General Notice", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-03-28T03:59:59Z", "2012-05-04T12:01:27Z", "2011-33188", 0, 0, "0900006480f8a26a"], ["FDA-2011-D-0652-0002", "FDA", "FDA-2011-D-0652", "Draft Guidance for Industry and Food and Drug Administration Staff The 510(k) Program Evaluating Substantial Equivalence in Premarket Notifications [510(k)]", "Other", "Guidance", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-04-27T03:59:59Z", "2014-09-27T01:07:24Z", null, 0, 0, "0900006480f8a513"], ["FDA-2011-D-0893-0002", "FDA", "FDA-2011-D-0893", "Draft Guidances for Industry and Staff Center for Devices and Radiological Health Appeals Processes", "Other", "Guidance", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-04-27T03:59:59Z", "2011-12-28T16:23:06Z", null, 0, 0, "0900006480f8a53c"], ["FDA-2011-P-0923-0002", "FDA", "FDA-2011-P-0923", "Acknowledgement Letter to Public Citizen Health Research Group", "Other", "Acknowledgement Letter/Receipt", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T22:30:59Z", null, 0, 0, "0900006480f88965"], ["FDA-2010-D-0313-0018", "FDA", "FDA-2010-D-0313", "Guidance for Industry; Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation", "Other", "Guidance", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2024-11-07T01:40:00Z", null, 1, 0, "0900006480f89bae"], ["FDA-2011-P-0913-0001", "FDA", "FDA-2011-P-0913", "KVK-Tech, Inc. - Citizen Petition", "Other", "Citizen Petition", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2013-01-31T14:54:18Z", null, 0, 0, "0900006480f847f5"], ["FDA-1997-S-0006-1139", "FDA", "FDA-1997-S-0006", "Nuvilex, Inc., LET1139 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T19:10:07Z", null, 0, 0, "0900006480f85d4b"], ["FDA-1997-S-0006-1142", "FDA", "FDA-1997-S-0006", "NatureGift (USA), Inc., LET1142 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T19:40:19Z", null, 0, 0, "0900006480f85d51"], ["FDA-1997-S-0006-1132", "FDA", "FDA-1997-S-0006", "Nutrition21, LET1132 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T16:34:57Z", null, 0, 0, "0900006480f85d3d"], ["FDA-1997-S-0006-1138", "FDA", "FDA-1997-S-0006", "Better Health Beverage (Foley & Lardner LLP.) LET1138 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T18:57:22Z", null, 0, 0, "0900006480f85d49"], ["FDA-2011-P-0734-0003", "FDA", "FDA-2011-P-0734", "FDA/CDER Response to Richard J. Miller - Petition Denial", "Other", "Denial of Petition", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T23:15:07Z", null, 0, 0, "0900006480f8a924"], ["FDA-2011-N-0002-0152", "FDA", "FDA-2011-N-0002", "Meetings: Cellular, Tissue, and Gene Therapies Advisory Committee", "Notice", "Meeting", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T20:10:31Z", "2011-33220", 0, 0, "0900006480f8a239"], ["FDA-2007-N-0265-0007", "FDA", "FDA-2007-N-0265", "Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers; Correction", "Rule", "Correction", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T20:10:32Z", "2011-33183", 0, 0, "0900006480f8a284"], ["FDA-2011-D-0893-0001", "FDA", "FDA-2011-D-0893", "Draft Guidances for Industry and Staff; Availability: Center for Devices and Radiological Health Appeals Processes", "Notice", "Notice of Availability", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", "2012-04-27T03:59:59Z", "2014-01-13T17:39:02Z", "2011-33230", 0, 0, "0900006480f8a2c3"], ["FDA-1997-S-0006-1134", "FDA", "FDA-1997-S-0006", "Source Naturals LET1134 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T17:14:06Z", null, 0, 0, "0900006480f85d41"], ["FDA-1997-S-0006-1133", "FDA", "FDA-1997-S-0006", "New Century Company LET1133 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T17:07:01Z", null, 0, 0, "0900006480f85d3f"], ["FDA-2010-D-0313-0017", "FDA", "FDA-2010-D-0313", "Guidance for Industry: Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation; Availability", "Notice", "Notice of Availability", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2024-11-07T01:39:58Z", "2011-33292", 1, 0, "0900006480f8a23c"], ["FDA-1997-S-0006-1135", "FDA", "FDA-1997-S-0006", "Planetary Ayurvedics LET1135 Response From FDA/CFSAN - Courtesy Letter", "Other", "Letter(s)", "2011-12-28T05:00:00Z", 2011, 12, "2011-12-28T05:00:00Z", null, "2011-12-28T17:20:39Z", null, 0, 0, "0900006480f85d43"], ["FDA-2011-P-0852-0001", "FDA", "FDA-2011-P-0852", "Dr. S. Albert Edwards - Citizen Petition", "Other", "Citizen Petition", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2016-05-17T10:48:51Z", null, 0, 0, "0900006480f74b19"], ["FDA-2011-N-0002-0151", "FDA", "FDA-2011-N-0002", "Requests for Nominations: Voting Members on Public Advisory Panels or Committees", "Notice", "General Notice", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T16:38:57Z", "2011-33060", 0, 0, "0900006480f898b3"], ["FDA-2011-N-0915-0001", "FDA", "FDA-2011-N-0915", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products, etc.", "Notice", "General Notice", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", "2012-02-28T04:59:59Z", "2011-12-27T16:45:58Z", "2011-33140", 0, 0, "0900006480f89156"], ["FDA-2011-D-0787-0003", "FDA", "FDA-2011-D-0787", "Draft Guidance for Industry and Staff; Availability: Investigational Device Exemptions for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human Studies", "Notice", "Notice of Extension", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", "2012-03-10T04:59:59Z", "2011-12-27T16:55:21Z", "2011-33142", 0, 0, "0900006480f89d41"], ["FDA-2011-D-0790-0004", "FDA", "FDA-2011-D-0790", "Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations", "Notice", "Notice of Extension", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", "2012-03-10T04:59:59Z", "2011-12-27T17:03:18Z", "2011-33141", 0, 0, "0900006480f89877"], ["FDA-2011-P-0852-0002", "FDA", "FDA-2011-P-0852", "Acknowledgement Letter to Dr. S. Albert Edwards", "Other", "Acknowledgement Letter/Receipt", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T19:31:22Z", null, 0, 0, "0900006480f74b64"], ["FDA-2011-N-0002-0150", "FDA", "FDA-2011-N-0002", "Requests for Nominations: Food Advisory Committee Voting Members", "Notice", "General Notice", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T16:32:38Z", "2011-33108", 0, 0, "0900006480f89874"], ["FDA-2011-N-0002-0149", "FDA", "FDA-2011-N-0002", "Endocrinologic and Metabolic Drugs Advisory Committee Meeting", "Notice", "Meeting", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T16:27:31Z", "2011-33059", 0, 0, "0900006480f89822"], ["FDA-1978-N-0021-0042", "FDA", "FDA-1978-N-0021", "FDA/CDER Maalox Total Relief Memo Meeting minutes and Quarterly Reports 12 9 11", "Other", "Report", "2011-12-27T05:00:00Z", 2011, 12, "2011-12-27T05:00:00Z", null, "2011-12-27T13:50:45Z", null, 0, 0, "0900006480f899cc"], ["FDA-2011-M-0866-0001", "FDA", "FDA-2011-M-0866", "Premarket Approval of Dako Denmark A/S HER2 CISH pharmDx\u2122 Kit", "Other", "Approval", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T19:22:55Z", null, 0, 0, "0900006480f80833"], ["FDA-2011-V-0895-0002", "FDA", "FDA-2011-V-0895", "Acknowledgement Letter to Laser Sky Designs", "Other", "Acknowledgement Letter/Receipt", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T19:10:11Z", null, 0, 0, "0900006480f805cf"], ["FDA-2011-A-0346-0003", "FDA", "FDA-2011-A-0346", "Acknowledgement Letter to Radiation Safety Committee, University of California, Irvine Medical Center", "Other", "Acknowledgement Letter/Receipt", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2014-01-20T20:06:38Z", null, 0, 0, "0900006480c6cd64"], ["FDA-2010-P-0222-0003", "FDA", "FDA-2010-P-0222", "Alaunus Pharmaceutical, LLC - Withdrawal", "Other", "Withdrawal", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T18:47:04Z", null, 0, 0, "0900006480f81d09"], ["FDA-2010-P-0460-0003", "FDA", "FDA-2010-P-0460", "Alaunus Pharmaceutical, LLC - Amendment", "Other", "Amendment", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T17:54:48Z", null, 0, 0, "0900006480f82074"], ["FDA-2011-A-0346-0002", "FDA", "FDA-2011-A-0346", "Radiation Safety Committee, University of California, Irvine Medical Center - Advisory Opinion", "Other", "Advisory Opinion Petition", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2014-01-20T20:20:54Z", null, 0, 0, "0900006480c6cd63"], ["FDA-2011-V-0894-0002", "FDA", "FDA-2011-V-0894", "Acknowledgement Letter to Hypnotix Entertainment", "Other", "Acknowledgement Letter/Receipt", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T18:59:17Z", null, 0, 0, "0900006480f805c8"], ["FDA-2011-V-0894-0001", "FDA", "FDA-2011-V-0894", "Hypnotix Entertainment - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T18:59:17Z", null, 0, 0, "0900006480f80586"], ["FDA-2011-V-0895-0001", "FDA", "FDA-2011-V-0895", "Laser Sky Designs - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-23T05:00:00Z", 2011, 12, "2011-12-23T05:00:00Z", null, "2011-12-23T19:10:10Z", null, 0, 0, "0900006480f805cc"], ["FDA-1977-N-0014-1438", "FDA", "FDA-1977-N-0014", "Withdrawal of Notices of Opportunity for a Hearing: Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2019-04-09T18:17:07Z", "2011-32775", 0, 0, "0900006480f87dc5"], ["FDA-2011-N-0508-0002", "FDA", "FDA-2011-N-0508", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Blood Establishment Registration and Product Listing", "Notice", "General Notice", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T17:02:14Z", "2011-32777", 0, 0, "0900006480f87cba"], ["FDA-2011-A-0346-0001", "FDA", "FDA-2011-A-0346", "FDA/CDER Response to Radiation Safety Committee, University of California, Irvine Medical Center - Letter", "Other", "Letter(s)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-23T18:35:16Z", null, 0, 0, "0900006480f854fd"], ["FDA-2001-P-0123-0186", "FDA", "FDA-2001-P-0123", "FDA-CDER/ to Center for Reproductive Rights - Petition Denial", "Other", "Denial of Petition", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T18:07:45Z", null, 0, 0, "0900006480f8816b"], ["FDA-2007-N-0475-0035", "FDA", "FDA-2007-N-0475", "FDA/OC  to Parties, from the Office of the Commissioner,  December 15, 2011 - Letter", "Other", "Letter(s)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T18:45:27Z", null, 0, 0, "0900006480f88195"], ["FDA-2011-P-0552-0003", "FDA", "FDA-2011-P-0552", "Robert Wagner to FDA's Division of Dockets Management - Letter", "Other", "Letter(s)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T21:26:14Z", null, 0, 0, "0900006480f8158b"], ["FDA-2011-V-0896-0002", "FDA", "FDA-2011-V-0896", "Acknowledgement Letter to Patete Taylor Films, Inc. dba Boulevard Films", "Other", "Acknowledgement Letter/Receipt", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:21:12Z", null, 0, 0, "0900006480f805fe"], ["FDA-1977-N-0019-0067", "FDA", "FDA-1977-N-0019", "Withdrawal of Notices of Opportunity for a Hearing; Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2019-04-25T18:21:26Z", "2011-32775", 0, 0, "0900006480f87c5a"], ["FDA-2011-V-0892-0001", "FDA", "FDA-2011-V-0892", "The Boys DJ - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T16:45:22Z", null, 0, 0, "0900006480f80581"], ["FDA-2011-M-0865-0001", "FDA", "FDA-2011-M-0865", "Premarket Approval of PROMUS\u00ae Element\u2122 Plus Everolimus-Eluting Platinum Coronary Stent System (Monorail\u2122 and Over-The-Wire)", "Other", "Approval", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T20:58:20Z", null, 0, 0, "0900006480f807f8"], ["FDA-2011-V-0897-0002", "FDA", "FDA-2011-V-0897", "Acknowledgement Letter to NLFX Professional", "Other", "Acknowledgement Letter/Receipt", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:27:57Z", null, 0, 0, "0900006480f80657"], ["FDA-2011-V-0891-0002", "FDA", "FDA-2011-V-0891", "Acknowledgement Letter to Lore2mix", "Other", "Acknowledgement Letter/Receipt", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T15:26:26Z", null, 0, 0, "0900006480f8057f"], ["FDA-1977-N-0022-0146", "FDA", "FDA-1977-N-0022", "Withdrawal of Notices of Opportunity for a Hearing: Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T16:45:03Z", "2011-32775", 0, 0, "0900006480f87ea8"], ["FDA-2011-N-0511-0002", "FDA", "FDA-2011-N-0511", "Agency Information Collection Activities; Proposals, Submissions, andApprovals: Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, etc.", "Notice", "General Notice", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T14:02:15Z", "2011-32778", 0, 0, "0900006480f87c31"], ["FDA-2011-N-0908-0001", "FDA", "FDA-2011-N-0908", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Establishment and Operation of Clinical Trial Data Monitoring Committees", "Notice", "General Notice", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", "2012-02-22T04:59:59Z", "2011-12-22T17:04:41Z", "2011-32776", 0, 0, "0900006480f87d15"], ["FDA-2011-V-0897-0001", "FDA", "FDA-2011-V-0897", "NLFX Professional - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:27:57Z", null, 0, 0, "0900006480f80602"], ["FDA-2011-N-0513-0010", "FDA", "FDA-2011-N-0513", "FDA/OC and ISTA Pharmaceuticals to G. Mathew Warren, FDA  Senior Regulatory Counsel, December 16, 2011 - Letter", "Other", "Letter(s)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:27:13Z", null, 0, 0, "0900006480f88124"], ["FDA-1977-N-0224-0138", "FDA", "FDA-1977-N-0224", "Withdrawal of Notices of Opportunity for a Hearing: Penicillin and Tetracycline Used in Animal Feed", "Notice", "Withdrawal", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2019-04-29T15:42:47Z", "2011-32775", 0, 0, "0900006480f87ed5"], ["FDA-2011-V-0892-0002", "FDA", "FDA-2011-V-0892", "Acknowledgement Letter to The Boys DJ", "Other", "Acknowledgement Letter/Receipt", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T16:45:22Z", null, 0, 0, "0900006480f80584"], ["FDA-2011-V-0891-0001", "FDA", "FDA-2011-V-0891", "Lore2mix - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T15:26:26Z", null, 0, 0, "0900006480f8057d"], ["FDA-2011-N-0411-0003", "FDA", "FDA-2011-N-0411", "Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications: Bristol-Myers Squibb Co., et al.; Correction", "Notice", "Correction", "2011-12-22T05:00:00Z", 2011, 12, null, null, "2011-12-22T17:07:37Z", "2011-32822", 0, 0, "0900006480f87d1a"], ["FDA-2010-P-0520-0007", "FDA", "FDA-2010-P-0520", "FDA/CDER/ to Extremity Innovations, Inc. - Petition Denial", "Other", "Denial of Petition", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T22:31:18Z", null, 0, 0, "0900006480f882c3"], ["FDA-2011-P-0552-0004", "FDA", "FDA-2011-P-0552", "FDA/CDRH Response to Robert Wagner - Petition Denial", "Other", "Denial of Petition", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T21:35:22Z", null, 0, 0, "0900006480f878b0"], ["FDA-2011-P-0645-0003", "FDA", "FDA-2011-P-0645", "FDA/CDER to Center for Inquiry and Committee for Skeptical Inquiry - Petition Denial", "Other", "Denial of Petition", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:22:27Z", null, 0, 0, "0900006480f88146"], ["FDA-2011-P-0484-0003", "FDA", "FDA-2011-P-0484", "Turtle Island Restoration (TIRN), and The Center for Biological Diversity (CBD) - Supplement", "Other", "Supplement (SUP)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2013-07-28T00:10:37Z", null, 0, 0, "0900006480f81d0b"], ["FDA-2011-P-0644-0003", "FDA", "FDA-2011-P-0644", "FDA-CDER/ to Center for Inquiry and Committee for Skeptical Inquiry - Petition Denial", "Other", "Denial of Petition", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:08:29Z", null, 0, 0, "0900006480f8812b"], ["FDA-2011-V-0896-0001", "FDA", "FDA-2011-V-0896", "Patete Taylor Films, Inc. dba Boulevard Films - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-22T05:00:00Z", 2011, 12, "2011-12-22T05:00:00Z", null, "2011-12-22T17:21:12Z", null, 0, 0, "0900006480f805fc"], ["FDA-2011-N-0902-0001", "FDA", "FDA-2011-N-0902", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Prescription Drug Product Labeling; Medication Guide Requirements", "Notice", "60 Day Proposed Information Collection", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2012-02-22T04:59:59Z", "2011-12-21T21:40:13Z", "2011-32548", 0, 0, "0900006480f87038"], ["FDA-2011-V-0877-0002", "FDA", "FDA-2011-V-0877", "Acknowledgement Letter to SLO DJ", "Other", "Acknowledgement Letter/Receipt", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T16:24:34Z", null, 0, 0, "0900006480f7c980"], ["FDA-2011-N-0656-0002", "FDA", "FDA-2011-N-0656", "Animal Drug User Fee Act; Reopening of Comment Period", "Notice", "Notice of Extension", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2013-01-16T04:59:59Z", "2013-01-16T03:07:49Z", "2011-32567", 0, 0, "0900006480f87129"], ["FDA-2011-V-0877-0001", "FDA", "FDA-2011-V-0877", "SLO DJ - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T16:24:34Z", null, 0, 0, "0900006480f7c961"], ["FDA-2011-N-0003-0054", "FDA", "FDA-2011-N-0003", "New Animal Drugs for Use in Animal Feeds: Monensin", "Rule", "Final Rule", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:06:14Z", "2011-32427", 0, 0, "0900006480f87099"], ["FDA-2011-P-0804-0003", "FDA", "FDA-2011-P-0804", "Bruno Independent Living Aids, Inc. - Letter", "Other", "Letter(s)", "2011-12-21T05:00:00Z", 2011, 12, "2011-11-09T05:00:00Z", null, "2013-08-11T04:49:15Z", null, 0, 0, "0900006480f7f21f"], ["FDA-2011-N-0003-0055", "FDA", "FDA-2011-N-0003", "New Animal Drugs: Change of Sponsor; Zinc Gluconate", "Rule", "Final Rule", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T22:32:43Z", "2011-32591", 0, 0, "0900006480f87170"], ["FDA-2011-V-0876-0002", "FDA", "FDA-2011-V-0876", "Acknowledgement Letter to Painted Bride Art Center", "Other", "Acknowledgement Letter/Receipt", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T16:19:26Z", null, 0, 0, "0900006480f7c94d"], ["FDA-2011-N-0842-0001", "FDA", "FDA-2011-N-0842", "Gluten in Drug Products", "Notice", "General Notice", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2012-03-21T03:59:59Z", "2011-12-21T21:31:22Z", "2011-32551", 0, 0, "0900006480f87037"], ["FDA-2011-N-0655-0003", "FDA", "FDA-2011-N-0655", "Animal Generic Drug User Fee Act; Reopening of Comment Period", "Notice", "Notice of Extension", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", "2013-01-16T04:59:59Z", "2012-12-11T03:01:51Z", "2011-32565", 0, 0, "0900006480f8703b"], ["FDA-2011-V-0876-0001", "FDA", "FDA-2011-V-0876", "Painted Bride Art Center - Application for Variance", "Other", "Application for Variance (VAR)", "2011-12-21T05:00:00Z", 2011, 12, "2011-12-21T05:00:00Z", null, "2011-12-21T16:19:25Z", null, 0, 0, "0900006480f7c91f"]], "truncated": false, "filtered_table_rows_count": 3966, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "2011"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2011", "results": [{"value": "FDA", "label": "FDA", "count": 3966, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?posted_year=2011", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2011", "results": [{"value": "Other", "label": "Other", "count": 2291, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 837, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&document_type=Notice", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 703, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 88, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&document_type=Rule", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 47, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2011", "results": [{"value": 2011, "label": 2011, "count": 3966, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_facet_date=last_modified"}], "next": "2011-12-21T05~3A00~3A00Z,FDA-2011-V-0876-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2011&_next=2011-12-21T05~3A00~3A00Z%2CFDA-2011-V-0876-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 444.79402498109266, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}